fluindione has been researched along with methylprednisolone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amoura, Z; Ankri, A; Aymard, G; Cacoub, P; Costedoat-Chalumeau, N; Diquet, B; Du, LT; Piette, JC; Sevin, O; Wechsler, B | 1 |
| Klein, I; Lidove, O; Papo, T; Sacré, K; Zaidan, M | 1 |
2 other study(ies) available for fluindione and methylprednisolone
| Article | Year |
|---|---|
Potentiation of vitamin K antagonists by high-dose intravenous methylprednisolone.
Topics: Acenocoumarol; Adult; Aged; Anticoagulants; Blood Coagulation Factors; Drug Synergism; Female; Humans; Infusions, Intravenous; International Normalized Ratio; Male; Methylprednisolone; Middle Aged; Phenindione; Prospective Studies; Protein C; Protein S; Prothrombin Time; Vitamin K | 2000 |
"Fulminant" Behçet disease.
Topics: Administration, Oral; Adolescent; Anti-Inflammatory Agents; Antibodies, Monoclonal; Atrophy; Azathioprine; Behcet Syndrome; C-Reactive Protein; Cyclophosphamide; Diagnosis, Differential; Drug Therapy, Combination; Emigrants and Immigrants; Female; Humans; Immunosuppressive Agents; Infliximab; Infusions, Intravenous; Magnetic Resonance Imaging; Methylprednisolone; Myelitis, Transverse; Neurologic Examination; Phenindione; Prednisolone; Pyoderma Gangrenosum; Spinal Cord; Spinal Cord Ischemia; Tumor Necrosis Factor-alpha | 2011 |